Serum neurofilament‐light and glial fibrillary acidic protein levels in hydroxychloroquine‐treated primary progressive multiple sclerosis
出版年份 2022 全文链接
标题
Serum neurofilament‐light and glial fibrillary acidic protein levels in hydroxychloroquine‐treated primary progressive multiple sclerosis
作者
关键词
-
出版物
EUROPEAN JOURNAL OF NEUROLOGY
Volume -, Issue -, Pages -
出版商
Wiley
发表日期
2022-10-10
DOI
10.1111/ene.15588
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Assessing Neurofilaments as Biomarkers of Neuroprotection in Progressive Multiple Sclerosis
- (2022) Thomas E. Williams et al. Neurology-Neuroimmunology & Neuroinflammation
- Serum Neurofilament Light and Multiple Sclerosis Progression Independent of Acute Inflammation
- (2022) Arie R. Gafson et al. JAMA Network Open
- Serum neurofilament light chain for individual prognostication of disease activity in people with multiple sclerosis: a retrospective modelling and validation study
- (2022) Pascal Benkert et al. LANCET NEUROLOGY
- Blood Neurofilament Light in Progressive Multiple Sclerosis
- (2022) David Leppert et al. NEUROLOGY
- Effect of Ocrelizumab in Blood Leukocytes of Patients With Primary Progressive MS
- (2021) José I. Fernández-Velasco et al. Neurology-Neuroimmunology & Neuroinflammation
- Neurofilament light chain in a phase 2 clinical trial of ibudilast in progressive multiple sclerosis
- (2021) Robert J Fox et al. Multiple Sclerosis Journal
- Profiling serum neurofilament light chain and glial fibrillary acidic protein in primary progressive multiple sclerosis
- (2021) James Giarraputo et al. JOURNAL OF NEUROIMMUNOLOGY
- The potential of serum neurofilament as biomarker for multiple sclerosis
- (2021) Stefan Bittner et al. BRAIN
- Optical Coherence Tomography and Visual Evoked Potentials as Prognostic and Monitoring Tools in Progressive Multiple Sclerosis
- (2021) Simone Guerrieri et al. Frontiers in Neuroscience
- Hydroxychloroquine for Primary Progressive Multiple Sclerosis
- (2021) Marcus W. Koch et al. ANNALS OF NEUROLOGY
- Mechanism-based criteria to improve therapeutic outcomes in progressive multiple sclerosis
- (2021) Heather Y. F. Yong et al. Nature Reviews Neurology
- Progressive Multiple Sclerosis Is Associated with Faster and Specific Retinal Layer Atrophy
- (2020) Elias S. Sotirchos et al. ANNALS OF NEUROLOGY
- Neurofilaments in progressive multiple sclerosis: a systematic review
- (2020) Thomas Williams et al. JOURNAL OF NEUROLOGY
- Serum neurofilament light chain and optical coherence tomography measures in MS
- (2020) Eleonora Tavazzi et al. Neurology-Neuroimmunology & Neuroinflammation
- Serum neurofilament light as a biomarker in progressive multiple sclerosis
- (2020) Raju Kapoor et al. NEUROLOGY
- Serum GFAP in multiple sclerosis: correlation with disease type and MRI markers of disease severity
- (2020) Xavier Ayrignac et al. Scientific Reports
- Glial Activation Markers in CSF and Serum From Patients With Primary Progressive Multiple Sclerosis: Potential of Serum GFAP as Disease Severity Marker?
- (2019) Ahmed Abdelhak et al. Frontiers in Neurology
- Blood neurofilament light chain as a biomarker of MS disease activity and treatment response
- (2019) Jens Kuhle et al. NEUROLOGY
- Plasma Neurofilaments correlate with Disability in Progressive Multiple Sclerosis patients
- (2019) Diana Ferraro et al. ACTA NEUROLOGICA SCANDINAVICA
- Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study
- (2018) Ludwig Kappos et al. LANCET
- Serum glial fibrillary acidic protein correlates with multiple sclerosis disease severity
- (2018) Heidi Högel et al. Multiple Sclerosis Journal
- Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis
- (2017) Xavier Montalban et al. NEW ENGLAND JOURNAL OF MEDICINE
- Retinal thickness measured with optical coherence tomography and risk of disability worsening in multiple sclerosis: a cohort study
- (2016) Elena H Martinez-Lapiscina et al. LANCET NEUROLOGY
- Hydroxychloroquine reduces microglial activity and attenuates experimental autoimmune encephalomyelitis
- (2015) Marcus W. Koch et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Retinal Axonal Loss Begins Early in the Course of Multiple Sclerosis and Is Similar between Progressive Phenotypes
- (2012) Jeffrey M. Gelfand et al. PLoS One
- Using retinal architecture to help characterize multiple sclerosis patients
- (2010) Fiona Costello et al. CANADIAN JOURNAL OF OPHTHALMOLOGY-JOURNAL CANADIEN D OPHTALMOLOGIE
- Rituximab in patients with primary progressive multiple sclerosis: Results of a randomized double-blind placebo-controlled multicenter trial
- (2009) Kathleen Hawker et al. ANNALS OF NEUROLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started